Skip to main content
. 2022 Aug 28;63(1):129–135. doi: 10.47162/RJME.63.1.13

Table 1.

The clinical and pathological characteristics of patients (n=156)

Variable

Values

Percent [%]

Age at diagnosis [years]

 

 

▪ Mean

58.9

 

▪ Range

34–82

Familial BrCa history

 

 

▪ Yes

5

3.20

▪ No

151

96.79

Oral contraceptives

 

 

▪ Never

62

39.74

▪ Constant

94

60.25

Menopausal status

 

 

▪ Premenopause

31

19.87

▪ Postmenopause

125

80.12

Size of the tumor [cm]

 

 

▪ Mean

3.8

 

▪ Variation

13.5

Lymphovascular invasion

 

 

▪ Present

65

41.66

▪ Absent

91

58.33

Lymph node status

 

 

▪ Negative

76

48.71

▪ 1–3 lymph nodes

44

28.20

▪ Over three lymph nodes

30

19.23

Grade

 

 

▪ G1

17

10.89

▪ G2

81

51.92

▪ G3

58

37.17

Histopathology

 

 

▪ Ductal invasive, NOS

130

83.33

▪ Lobular invasive

6

3.84

▪ Medullary

7

4.48

▪ Mucinous

2

1.28

▪ Metaplastic

9

5.76

▪ Papillary

2

1.28

Nottingham Prognostic Index (NPI)

 

 

▪ Less than 3.4

15

9.61

▪ 3.4–5.4

68

43.58

▪ Over 5.4

32

20.51

▪ Not done

41

26.28

Local recurrence

 

 

▪ Yes

12

7.69

▪ No

144

92.30

BrCa: Breast cancer; NOS: Not otherwise specified